Menú

EMAP
Grup d’Estudis de Medicament en Atenció Primària (EMAP)

RESPONSABLE DEL GRUP
40882722S - Rosa Morros Pedrós - OK retall
Rosa Morros Pedrós
rmorros@idiapjgol.org
avatar_grups_recerca.png

Publicacions

Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol

F. CORDERO, S. MONNE, J. ORTEGA, A. GARCIA-SANGENIS, O. PUERTOLAS, S. CONTRERAS-MARTOS, G. MUNOZ, R. ESCOLA, M. JOUE, R. PEDROS and B. SALVADOR-GONZALEZ
Trials. 2022 Jan 6; . doi:10.1186/s13063-021-05951-w; PMID:34991703

Veure més:
Experiences prescribing medicines, alternative treatments and vaccines among health professionals in Catalonia (Spain): A qualitative study

B. MUNNE-BARELLAS, A. GARCÍA-EGEA, R. MORROS-PEDRÓS, C. VEDIA-URGELL, M. GINER-SORIANO and L. MEDINA-PERUCHA
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2024 Oct 1;

Veure més:
Risk of psychiatric events in women treated with isotretinoin: a self-controlled study with SIDIAP database

G. VONA-GIRALT, C. VILAPLANA-CARNERERO, D. OUCHI, A. GOMEZ-LUMBRERAS, R. MORROS and M. GINER-SORIANO
Expert Opinion On Drug Safety. 2023 Mar 4; . doi:10.1080/14740338.2022.2120608; PMID:36045482

Veure més:
Pharmacological treatment of the heart failure according to the ventricular ejection fraction in primary care

M. GINER-SORIANO, D. BAENA, D. OUCHI, A. GOMEZ-LUMBRERAS and R. MORROS
Atencion Primaria. 2022 Aug 1; . doi:10.1016/j.aprim.2022.102362; PMID:35777241

Veure més:
Risk of thrombotic events and other complications in anticoagulant users infected with SARS-CoV-2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain)

M. GINER-SORIANO, A. GOMEZ-LUMBRERAS, C. VEDIA, D. OUCHI and R. MORROS
BMC Primary Care. 2022 Jun 8; . doi:10.1186/s12875-022-01752-5; PMID:35676639

Veure més:

Patronat

Col·laboradors

Acreditacions